查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514239

心律管理 (CRM) 設備的全球市場

Cardiac Rhythm Management (CRM) Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球心律管理 (CRM) 設備市場預計將達到 239 億美元

心律管理 (CRM) 設備的全球市場預計 2023 年為 185 億美元，預計到 2030 年將達到 239 億美元，2023 年至 2030 年複合年成長率為 3.8%。心臟去顫器是本報告分析的細分市場之一，預計複合年成長率為 4.4%，到分析期結束時將達到 113 億美元。分析期間心律調節器產業的複合年成長率預計為 3.6%。

美國市場預計50億美元，中國預計複合年成長率6.6%

到 2023 年，美國心律管理 (CRM) 設備市場預計將達到 50 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達50億美元，2023-2030年分析期間複合年成長率為6.6%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 0.9% 和 4.4%。在歐洲，德國的複合年成長率預計為 1.8%。

全球心律管理 (CRM) 設備市場 - 主要趨勢與促進因素總結

心律管理（CRM）設備在醫療領域對於心率和其他相關心臟疾病的診斷和治療發揮著至關重要的作用。這些設備包括旨在確保正常心臟功能的各種產品，例如心律調節器、植入式心臟整流去顫器(ICD) 和心臟再同步治療 (CRT) 設備。心律調節器主要用於透過發送刺激穩定心率的電脈衝來控制心搏過緩。另一方面，ICD 持續監測心律並在嚴重心律不整或心臟麻痹停發作時提供挽救生命的電擊以恢復正常心律。 CRT 對心臟衰竭患者特別有益，因為它可以調節心室收縮並提高每次心率的效率。 CRM 設備取得了重大技術進步，包括無引線心律調節器的開發，它消除了對引線的需求，並降低了感染和手術併發症的風險。此外，與MRI相容的CRM設備也出現了，使得以前被認為是禁忌的磁振造影現在可以安全地進行。

由於心血管疾病盛行率的上升以及先進診斷和治療技術的日益採用，CRM 設備市場正在經歷顯著成長。心血管疾病仍然是全球死亡的主要原因之一，影響著數百萬人，並對有效的管理解決方案產生了巨大的需求。世界人口老化，更容易罹患心臟病，進一步增加了對 CRM 設備的需求。此外，將遠端監控系統整合到 CRM 設備中將實現對心律的連續即時監控並促進及時的醫療干預，從而徹底改變患者照護。透過及早發現潛在問題，此類遠距系統不僅可以改善病患的治療效果，還可以減少頻繁去醫院和重新入院的需要，最終降低醫療費用。醫療保健提供者擴大採用此類先進的 CRM 設備來提高護理品質。此外，已開發市場和新興市場有利的報銷政策和不斷上漲的醫療保健成本正在推動 CRM 設備在各種醫療保健環境中的採用。

CRM 設備市場的成長受到多種因素的推動，例如技術進步、心血管疾病盛行率上升以及對微創手術的偏好。無線 CRM 設備和人工智慧整合等技術創新大大提高了 CRM 設備的功能和患者便利性，從而提高了採用率。無導線心律調節器和 MRI 相容設備的市場開拓為患者提供了更安全、更通用的選擇，擴大了潛在市場。心血管疾病的日益普及和人口老化增加了對 CRM 設備作為有效管理工具的需求。此外，向門診治療和居家照護模式的轉變正在推動對可攜式監控 CRM 設備的需求。監管核准和標準在確保這些設備的安全性和有效性以及推動其市場推廣方面也發揮著重要作用。此外，新興市場不斷擴大的醫療基礎設施和對心臟護理設施的投資增加，使先進的 CRM 技術可供更廣泛的患者群體使用，從而創造了新的成長機會。它反映了對創新和有效的心臟護理解決方案日益成長的需求，並支撐了 CRM 設備市場的強勁成長軌跡。

受訪企業舉例（共34家）

  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic, Inc.
  • Physio-Control, Inc.
  • Schiller AG
  • ZOLL Medical Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-6132

Global Cardiac Rhythm Management (CRM) Devices Market to Reach US$23.9 Billion by 2030

The global market for Cardiac Rhythm Management (CRM) Devices estimated at US$18.5 Billion in the year 2023, is expected to reach US$23.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Defibrillators, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Pacemakers segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 6.6% CAGR

The Cardiac Rhythm Management (CRM) Devices market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Cardiac Rhythm Management (CRM) Devices Market - Key Trends and Drivers Summarized

Cardiac Rhythm Management (CRM) devices are crucial in the medical field for diagnosing and treating irregular heart rhythms and other related cardiac conditions. These devices include a diverse array of products such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, all designed to ensure proper heart function. Pacemakers are primarily used to manage bradycardia by sending electrical impulses to stimulate a consistent heartbeat. ICDs, on the other hand, continuously monitor heart rhythms and deliver life-saving shocks to restore normal rhythm during episodes of severe arrhythmias or sudden cardiac arrest. CRT devices are particularly beneficial for patients with heart failure, as they coordinate the contractions of the heart's ventricles, improving the efficiency of each heartbeat. The CRM device landscape has seen substantial technological advancements, such as the development of leadless pacemakers, which eliminate the need for leads (wires) and thereby reduce infection risks and procedural complications. Additionally, MRI-compatible CRM devices have emerged, allowing patients with these implants to safely undergo magnetic resonance imaging, which was previously contraindicated.

The market for CRM devices is experiencing significant growth driven by the rising prevalence of cardiovascular diseases and the increasing adoption of advanced diagnostic and therapeutic technologies. Cardiovascular diseases remain one of the leading causes of mortality worldwide, affecting millions of people and creating a substantial demand for effective management solutions. The aging global population, which is more susceptible to cardiac conditions, further drives the need for CRM devices. Moreover, the integration of remote monitoring systems in CRM devices has revolutionized patient care by enabling continuous, real-time monitoring of heart rhythms, thereby facilitating timely medical interventions. These remote systems not only improve patient outcomes by providing early detection of potential issues but also reduce the need for frequent hospital visits and readmissions, ultimately lowering healthcare costs. Healthcare providers are increasingly adopting these advanced CRM devices to enhance the quality of care. Additionally, favorable reimbursement policies and growing healthcare expenditure in both developed and emerging markets are bolstering the adoption of CRM devices across various healthcare settings.

The growth in the CRM devices market is driven by several factors, including technological advancements, the rising incidence of cardiovascular diseases, and the growing preference for minimally invasive procedures. Technological innovations, such as wireless CRM devices and the integration of artificial intelligence, have significantly enhanced the functionality and patient-friendliness of these devices, leading to increased adoption. The development of leadless pacemakers and MRI-compatible devices has expanded the addressable market by offering safer and more versatile options for patients. The increasing prevalence of cardiovascular diseases, coupled with an aging population, has heightened the demand for CRM devices as effective management tools. Moreover, the shift towards outpatient procedures and home-based care models has driven the demand for portable and remotely monitored CRM devices. Regulatory approvals and standards have also played a crucial role in propelling market adoption, ensuring the safety and efficacy of these devices. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising investments in cardiac care facilities have generated new growth opportunities, making advanced CRM technologies more accessible to a broader patient population. These factors collectively underscore the robust growth trajectory of the CRM devices market, reflecting the increasing need for innovative and effective cardiac care solutions.

Select Competitors (Total 34 Featured) -

  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic, Inc.
  • Physio-Control, Inc.
  • Schiller AG
  • ZOLL Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiac Rhythm Management (CRM) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Diseases Spurs Demand for CRM Devices
    • Advances in Wireless CRM Technologies Propel Growth
    • Increasing Adoption of Remote Monitoring Systems Strengthens Business Case for CRM Devices
    • Technological Innovations in Leadless Pacemakers Expand Addressable Market Opportunity
    • Growing Awareness and Early Diagnosis of Cardiac Disorders Drive Market Adoption
    • Integration of AI in CRM Devices Generates Demand
    • Rising Healthcare Expenditure Sustains Market Growth
    • Aging Population and Associated Cardiac Conditions Propel Growth in CRM Device Utilization
    • Development of MRI-Compatible CRM Devices Expands Addressable Market
    • Increasing Investments in Cardiac Care Facilities Generate Opportunities for Market Expansion
    • Shift Towards Outpatient Procedures Spurs Growth in CRM Devices Market
    • Innovations in Battery Life and Device Longevity Strengthen Business Case for Adoption
    • Growing Use of CRM Devices in Emerging Economies Expands Addressable Market Opportunity
    • Focus on Reducing Hospital Readmissions Generates Demand for Advanced CRM Solutions
    • Rising Number of Cardiac Rehabilitation Programs Strengthens Business Case for CRM Devices
    • Focus on Personalized Medicine and Tailored Cardiac Treatments Drives Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Rhythm Management (CRM) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Resynchronization Therapy (CRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030

IV. COMPETITION